Pfizer's experimental respiratory syncytial virus (RSV) vaccine was 82% effective in preventing severe infections in infants when given to expecting mothers in the second...
Sinopharm said on Friday its biotech unit has received regulatory approval for clinical trials of its mRNA COVID-19 vaccine targeting the Omicron variant.
The unit,...
Vaccines company Valneva on Monday reported positive 12-month antibody persistence data for its single-shot Chikungunya vaccine candidate.
The firm said in a statement it was...
US drugmaker Pfizer and German partner BioNTech SE said on Friday their Omicron-tailored shot targeting the BA.4/5 subvariants produced a strong antibody response in...
China's CanSino Biologics said on Sunday that its recently developed COVID-19 vaccine has been approved by the country's drug regulator for emergency use as...
The World Health Organization (WHO) on Thursday recommended the use of French drugmaker Valneva's COVID-19 vaccine.
The UN agency also recommended the use of a...
Britain has become the first country to approve a COVID-19 vaccine that targets both the original and Omicron variant of the virus.
The UK medicines...
South Africa's health regulator reported on Thursday a causal link between the death of an individual and Johnson & Johnson's (J&J) COVID-19 vaccine, the...
The European Medicines Agency (EMA) is recommending Novavax's COVID-19 vaccine carry a warning of two types of heart inflammation, based on a small number...
Canada on Thursday authorized Moderna COVID-19 vaccine for babies as young as 6 months old, making it the country's first vaccine against coronavirus for...
Sinovac's Covid-19 vaccine (CoronaVac) has been approved by the Brazilian Health Regulatory Agency (Anvisa) for emergency use in children from 3 to 5 years...
The US Food and Drug Administration said on Friday it has granted full approval to Pfizer and BioNTech's COVID-19 vaccine for adolescents aged between...
Germany's BioNTech, Pfizer's partner in COVID-19 vaccines, said the two companies would start tests on humans of next-generation shots that protect against a wide...